Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 3/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | FNTA | P49354 | 3/20 | 0.39 |
| ▸ | FNTB | P49356 | 3/20 | 0.39 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.38 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.38 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9329872 | 0.77 | ALDH1A1 (0.49) | ALOX15TSHRALDH1A1FNTAFNTB | |
| SCHEMBL6244701 | 0.77 | ALDH1A1 (0.49) | ALOX15TSHRALDH1A1FNTAFNTB | |
| SCHEMBL873011 | 0.76 | ALOX15 (0.46) | ALOX15TSHRALDH1A1CYP2D6CYP2C19 | |
| SCHEMBL8863826 | 0.76 | ALDH1A1 (0.60) | ALOX15TSHRALDH1A1FNTAFNTB | |
| SCHEMBL11689424 | 0.75 | ALOX15 (0.47) | ALOX15TSHRALDH1A1CYP2D6CYP2C19 | |
| SCHEMBL5369538 | 0.72 | ALDH1A1 (0.51) | ALOX15TSHRALDH1A1FNTAFNTB | |
| SCHEMBL29791313 | 0.72 | ALOX15 (0.44) | ALOX15TSHRALDH1A1FNTAFNTB | |
| SCHEMBL22111105 | 0.71 | ALDH1A1 (0.41) | ALOX15TSHRALDH1A1FNTAFNTB | |
| SCHEMBL23892698 | 0.71 | ALOX15 (0.52) | ALOX15TSHRALDH1A1KDM4EUSP2 | |
| SCHEMBL22111423 | 0.71 | ALOX15 (0.52) | ALOX15TSHRALDH1A1KDM4EUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3512631-B1 | USES OF VANADIUM TO OXIDIZE ALDEHYDES AND OZONIDES | P2 SCIENCE INC (US) | 2022-03-23 | — | — | EP | claimed |
| US-10696605-B2 | Uses of vanadium to oxidize aldehydes and ozonides | P2 SCIENCE, INC. (US) | 2020-06-30 | — | — | US | claimed |
| US-20190225558-A1 | USES OF VANADIUM TO OXIDIZE ALDEHYDES AND OZONIDES | P2 SCIENCE, INC. | 2019-07-25 | — | — | US | claimed |
| EP-3512631-A1 | USES OF VANADIUM TO OXIDIZE ALDEHYDES AND OZONIDES | P2 Science, Inc. (US) | 2019-07-24 | — | — | EP | claimed |
| WO-2018053289-A1 | USES OF VANADIUM TO OXIDIZE ALDEHYDES AND OZONIDES | P2 SCIENCE, INC. (US) | 2018-03-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10696605-B2 | Uses of vanadium to oxidize aldehydes and ozonides | NOX4, AOX1, ADH1C | ALOX15 19/4885TSHR 4266/4885ALDH1A1 216/4885 |
| US-20190225558-A1 | USES OF VANADIUM TO OXIDIZE ALDEHYDES AND OZONIDES | NOX4, AOX1, ADH1C | ALOX15 19/4885TSHR 4266/4885ALDH1A1 216/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.